Development of Novel M1 Antagonist Scaffolds Through the Continued Optimization of the MLPCN Probe ML012
Bioorganic and Medicinal Chemistry Letters - United Kingdom
doi 10.1016/j.bmcl.2012.06.018
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2012
Authors
Publisher
Elsevier BV